These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8733748)

  • 1. Peptidase inhibitors potentiate the effects of neurotensin and neuromedin N on self-stimulation of the medial prefrontal cortex.
    Fernández R; Alba F; Ferrer JM
    Neuroreport; 1996 Feb; 7(3):798-800. PubMed ID: 8733748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromedin N decreases self-stimulation of the medial prefrontal cortex.
    Ferrer JM; Sabater R; Sáez JA
    Neuroreport; 1992 Nov; 3(11):1027-9. PubMed ID: 1482762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediation by neurotensin-receptors of effects of neurotensin on self-stimulation of the medial prefrontal cortex.
    Fernández R; Sabater R; Sáez JA; Montes R; Alba F; Ferrer JM
    Br J Pharmacol; 1996 Sep; 119(2):299-302. PubMed ID: 8886412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothermic effect of neuromedin N in mice and its potentiation by peptidase inhibitors.
    Dubuc I; Nouel D; Coquerel A; Menard JF; Kitabgi P; Costentin J
    Eur J Pharmacol; 1988 Jun; 151(1):117-21. PubMed ID: 3416919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotensin participates in self-stimulation of the medial prefrontal cortex in the rat.
    Ferrer JM; Sabater R; Saez JA
    Eur J Pharmacol; 1993 Jan; 231(1):39-45. PubMed ID: 8444280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of microinjections of cholecystokinin and neurotensin into lateral hypothalamus and ventral mesencephalon on intracranial self-stimulation.
    Singh J; Desiraju T; Raju TR
    Pharmacol Biochem Behav; 1997 Dec; 58(4):893-8. PubMed ID: 9408192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central neurotensin receptor activation produces differential behavioral responses in Fischer and Lewis rats.
    Bauco P; Rompré PP
    Psychopharmacology (Berl); 2003 Jul; 168(3):253-61. PubMed ID: 12682711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of thiorphan, bestatin and a novel metallopeptidase inhibitor JMV 390-1 on the recovery of neurotensin and neuromedin N released from mouse hypothalamus.
    Kitabgi P; Dubuc I; Nouel D; Costentin J; Cuber JC; Fulcrand H; Doulut S; Rodriguez M; Martinez J
    Neurosci Lett; 1992 Aug; 142(2):200-4. PubMed ID: 1454216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological role and degradation processes of neuromedin N in the gastrointestinal tract: an in vitro and in vivo study.
    Barelli H; Woskowska Z; Cipris S; Fox-Threlkeld JE; Daniel EE; Vincent JP; Checler F
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1300-7. PubMed ID: 8531096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesencephalic microinjections of neurotensin-(1-13) and its C-terminal fragment, neurotensin-(8-13), potentiate brain stimulation reward.
    Rompré PP; Gratton A
    Brain Res; 1993 Jul; 616(1-2):154-62. PubMed ID: 8358607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptidase inhibitor-induced antidiuresis mediated through angiotensin and opioid receptors in the rat hypothalamus.
    Tsushima H; Mori M; Matsuda T
    Jpn J Pharmacol; 1996 May; 71(1):61-71. PubMed ID: 8791172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCH 23390 decreases self-stimulation of the medial prefrontal cortex in the rat.
    Sabater R; Saez JA; Ferrer JM
    Eur J Pharmacol; 1993 Sep; 242(2):205-8. PubMed ID: 8253117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prefrontal cortex microinjection of neurotensin-(8-13) on midbrain dopamine and non-dopamine cell firing.
    Fatigati MD; Anderson RM; Rompré P
    Brain Res; 2000 Sep; 876(1-2):196-200. PubMed ID: 10973609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromedin N: high affinity interaction with brain neurotensin receptors and rapid inactivation by brain synaptic peptidases.
    Checler F; Vincent JP; Kitabgi P
    Eur J Pharmacol; 1986 Jul; 126(3):239-44. PubMed ID: 3019713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of neurotensin on the release of glutamic acid in the prefrontal cortex and striatum of the rat.
    Sanz B; Exposito I; Mora F
    Neuroreport; 1993 Sep; 4(10):1194-6. PubMed ID: 8106002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effects of mesencephalic injections of neurotensin(1-13) and neuromedin N on brain electrical self-stimulation.
    Rompré PP; Gratton A
    Peptides; 1992; 13(4):713-9. PubMed ID: 1437713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of neurotensin receptors in the prefrontal cortex stimulates midbrain dopamine cell firing.
    Rompré PP; Boye SM; Moisan J
    Eur J Pharmacol; 1998 Jan; 341(2-3):169-72. PubMed ID: 9543236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone-insensitive potentiation of neurotensin hypothermic effect by the enkephalinase inhibitor thiorphan.
    Coquerel A; Dubuc I; Menard JF; Kitabgi P; Costentin J
    Brain Res; 1986 Nov; 398(2):386-9. PubMed ID: 3542125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation by thiorphan and bestatin of the naloxone-insensitive analgesic effects of neurotensin and neuromedin n.
    Coquerel A; Dubuc I; Kitaegi P; Costentin J
    Neurochem Int; 1988; 12(3):361-6. PubMed ID: 20501239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A C-terminal cyclic 8-13 neurotensin fragment analog appears less exposed to neprilysin when it crosses the blood-brain barrier than the cerebrospinal fluid-brain barrier in mice.
    Van Kemmel FM; Dubuc I; Bourdel E; Fehrentz JA; Martinez J; Costentin J
    Neurosci Lett; 1996 Oct; 217(1):58-60. PubMed ID: 8905739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.